NCT00538434 arm group c81e728d9d4c2f636f067f89cc14862c [clinicaltrials_resource:NCT00538434/arm-group/c81e728d9d4c2f636f067f89cc14862c]
NCT00538434 arm group c81e728d9d4c2f636f067f89cc14862c [clinicaltrials_resource:NCT00538434/arm-group/c81e728d9d4c2f636f067f89cc14862c]
Bio2RDF identifier
NCT00538434/arm-group/c81e728d9d4c2f636f067f89cc14862c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 1e728d9d4c2f636f067f89cc14862c
description [clinicaltrials_vocabulary:description]
Reslizumab 2 mg/kg
identifier
clinicaltrials_resource:NCT00538434/arm-group/c81e728d9d4c2f636f067f89cc14862c
title
NCT00538434 arm group c81e728d9d4c2f636f067f89cc14862c
@en
type
label
NCT00538434 arm group c81e728d ...... e728d9d4c2f636f067f89cc14862c]
@en